NCT07747753

Brief Summary

The goal of this clinical trial is to compare the effect of cold atmospheric plasma versus sodium hypochlorite as irrigating solutions in necrotic single rooted teeth. The main questions it aims to answer are:

  • Does the use of sodium hypochlorite solution or cold atmospheric plasma as root canal irrigant will have the same effect on the level of postoperative pain in necrotic single rooted teeth?
  • Does the use of sodium hypochlorite solution or cold atmospheric plasma as root canal irrigant will have the same effect on the level of MMP -9 in necrotic single rooted teeth? Researchers will compare cold atmospheric plasma to sodium hypochlorite solution as root canal irrigant to see if cold atmospheric plasma works to have the same effect on the level of postoperative pain and levels of MMP -9 in necrotic single rooted teeth. Participants will:
  • be asked to rate their pain level according to the given instructions and will be asked to return for follow up after 2 days to hand the pain scale chart.
  • be instructed to call the operator and will be permitted to take Ibuprofen 400 mg not more than 6 hours apart and to record their tablet intake within 48 hours postoperatively, in case of severe or persistent pain.
  • be referred to the fixed prosthodontics department for final restoration.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
5mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Aug 2026Mar 2027

First Submitted

Initial submission to the registry

July 31, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 5, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

August 5, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

July 31, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

cold atmospheric plasmapost-operative painnecrotic pulpsodium hypochloriteMMP

Outcome Measures

Primary Outcomes (1)

  • Post-operative pain

    Postoperative pain intensity will be measured at 6, 12, 24 and 48 hours and one week after the two visits following disinfection protocol in the first visit and after obturation in the second visit: Each patient will receive a pain chart containing 4 numerical rating scales; one for each time interval. The patient will be instructed to rate his/her pain level at the corresponding time interval on a scale from zero to 10, where a score of zero indicates absence of pain, a score from 1 to 3 indicates mild pain, a score from 4 to 6 indicates moderate pain and a score from 7 to 10 indicates severe pain (Youssif et al. 2025).

    6,12,24,48 hours and 7 days postoperative following the two visits.

Secondary Outcomes (1)

  • MMP-9 level

    After access cavity preparation (S-1), after application of disinfection protocol (S-2) & after one-week pre-obturation (S-3)

Study Arms (2)

Application of cold atmospheric plasma

EXPERIMENTAL

root canal disinfection protocol

Other: Application of cold atmospheric plasma

2.5% sodium hypochlorite

ACTIVE COMPARATOR

irrigation solution

Other: Application of cold atmospheric plasma

Interventions

root canal disinfection protocol

2.5% sodium hypochloriteApplication of cold atmospheric plasma

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients in good physical health; American Society of Anesthesiologists (ASA) class I or II, with no known allergic manifestations to the drugs used in the study and no involvement with other medication during the study (Appendix)
  • Patient's age between 18-55 years.
  • Male and female patients.
  • Patients who can understand the numerical rating scale (Appendix 4).
  • Patients who accept to participate in the trial and can sign the informed consent (Appendix 1).
  • Mature mandibular premolar teeth with:
  • Negative response to electric pulp tester.
  • No intra-canal calcifications or internal resorptive lesions.

You may not qualify if:

  • Medically compromised patients having substantive functional limitations (ASA III or IV) (Appendix 2).
  • Patients having two or more adjacent teeth requiring endodontic treatment.
  • Patients who received antibiotic therapy within the last three months before treatment (Rôças et al., 2016).
  • Patients administered analgesics in the last 24 hours before treatment.
  • Teeth with:
  • Vital pulps.
  • Immature apices.
  • Acute periapical abscess, swellings and facial cellulitis.
  • Periodontally affected (mobility grade II or III).
  • Previous root canal treatment.
  • Non-restorable coronal portion.
  • TMJ problems, bruxism or traumatic occlusion.
  • Inability to perceive the given instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry, Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Dental Pulp NecrosisPain, Postoperative

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative ComplicationsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Manar Yosri Fouda, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The microbiologist will be blinded to the treatment groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

July 31, 2026

First Posted

August 5, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

August 5, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations